← Open Payments lookup

RAYMOND MOLDEN: Open Payments

NPI 1477585982 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$592 in 35 payments from 10 companies in 2025. Trend: 2023 $537 · 2024 $464 · 2025 $592

Food & beverage: $592
CompanyPaymentsAmount
ABBVIE INC.15$201
Janssen Pharmaceuticals, Inc4$88
Takeda Pharmaceuticals U.S.A., Inc.4$63
Neurocrine BioSciences, Inc.2$53
Otsuka America Pharmaceutical, Inc.3$50
Corium, LLC2$35
Collegium Pharmaceutical, Inc.2$34
Axsome Therapeutics, Inc.1$24
Vanda Pharmaceuticals Inc.1$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22

Products named: VRAYLAR, INVEGA SUSTENNA, TRINTELLIX, INGREZZA, REXULTI, Azstarys, Jornay PM, Auvelity.

Industry payments across AR — which companies pay providers there.